other

Updated:

Digirad Corporation

Digirad Corporation, controlled by Jeffrey Eberwein, is a Suwanee-based holding company allocating capital across healthcare and industrial assets.

Digirad Corporation

Digirad Corporation was founded in 1985 as a medical-imaging firm. By 2016, under chairman Jeffrey Eberwein, it shifted toward an acquisition-and-holding strategy, pivoting away from equipment sales into a vehicle that owns and manages a portfolio of businesses and investments. The firm deploys capital across healthcare services, medical devices, and industrial manufacturing, with occasional real estate holdings. Public filings show it holds positions in companies such as Digirad Imaging Solutions and related healthcare entities. Its geographic footprint centers on the United States, with operations in Georgia and other domestic locations. Digirad employs roughly 50 people, per recent filings. It does not operate as a traditional asset manager; rather, it functions as a publicly traded mini-conglomerate controlled by Eberwein and his affiliates. No separate philanthropic or adjacent vehicles are publicly disclosed. Digirad's structural differentiator is its public-company form: it provides liquidity via a traded stock while operating with the strategic flexibility of a holding company. This hybrid allows the controlling shareholder to allocate capital without the regulatory constraints of a family office or the fund lifecycle pressure of a private investment firm.

General information

Firm type

other

Year founded

1985

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Suwanee

Corporate office

Suwanee, GA, United States

Principals

Jeffrey E. Eberwein

Chairman

Matthew G. Molchan

President and CEO

Sector focus

Healthcare ServicesMedical DevicesIndustrial Tech

Frequently asked questions

Who controls investment decisions at Digirad Corporation?

Chairman Jeffrey Eberwein, through his affiliated entities, controls the strategic direction. President and CEO Matthew Molchan runs day-to-day operations. The board, as disclosed in SEC filings, oversees major capital allocation moves.

Does Digirad function as a family office or a traditional operating company?

Digirad is a publicly traded holding company, not a single or multi-family office. However, its concentrated ownership structure and capital deployment strategy resemble a small family office within a public shell, allowing flexible allocation across industries.

What investment stages and sectors does Digirad target?

Digirad targets mature businesses in healthcare services, medical devices, and industrial manufacturing. It does not pursue early-stage ventures or fund-of-funds investments. Its holdings tend to be cash-flow-generating, lower-growth businesses.

How does Digirad source proprietary deal flow?

Its deal flow comes primarily through industry contacts and strategic acquisitions of small- to mid-sized companies in healthcare and industrial niches. The firm does not maintain a formal external fund or solicitation process.

Is Digirad related to any specific family or fortune?

The wealth behind Digirad's controlling stake traces to Jeffrey Eberwein, a well-known activist investor and former hedge fund manager. The firm acts as a personal investment vehicle for his capital and that of his affiliates.

Does Digirad invest via fund commitments or only direct ownership?

Digirad primarily takes direct ownership stakes in operating companies. It does not act as a limited partner in external private-equity funds, based on public disclosures.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo